Literature DB >> 31011189

Treg cell IL-10 and IL-35 exhaust CD8+ T cells in tumors.

Martina Damo1, Nikhil S Joshi2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31011189     DOI： 10.1038/s41590-019-0389-y

Source DB:  PubMed          Journal:  Nat Immunol        ISSN： 1529-2908            Impact factor:   25.606


× No keyword cloud information.
  2 in total

1.  Inhibitory and stimulatory effects of IL-10 on human CD8+ T cells.

Authors:  H Groux; M Bigler; J E de Vries; M G Roncarolo
Journal:  J Immunol       Date:  1998-04-01       Impact factor: 5.422

2.  Adaptive plasticity of IL-10+ and IL-35+ Treg cells cooperatively promotes tumor T cell exhaustion.

Authors:  Deepali V Sawant; Hiroshi Yano; Maria Chikina; Qianxia Zhang; Mengting Liao; Chang Liu; Derrick J Callahan; Zhe Sun; Tao Sun; Tracy Tabib; Arjun Pennathur; David B Corry; James D Luketich; Robert Lafyatis; Wei Chen; Amanda C Poholek; Tullia C Bruno; Creg J Workman; Dario A A Vignali
Journal:  Nat Immunol       Date:  2019-04-01       Impact factor: 25.606
  2 in total
  9 in total

Review 1.  Immunotherapy and immunoengineering for breast cancer; a comprehensive insight into CAR-T cell therapy advancements, challenges and prospects.

Authors:  Azam Bozorgi; Maryam Bozorgi; Mozafar Khazaei
Journal:  Cell Oncol (Dordr)       Date:  2022-08-09       Impact factor: 7.051

Review 2.  Knowns and Unknowns about CAR-T Cell Dysfunction.

Authors:  Aleksei Titov; Yaroslav Kaminskiy; Irina Ganeeva; Ekaterina Zmievskaya; Aygul Valiullina; Aygul Rakhmatullina; Alexey Petukhov; Regina Miftakhova; Albert Rizvanov; Emil Bulatov
Journal:  Cancers (Basel)       Date:  2022-02-21       Impact factor: 6.639

3.  Transcriptomic Analysis Identified ARHGAP Family as a Novel Biomarker Associated With Tumor-Promoting Immune Infiltration and Nanomechanical Characteristics in Bladder Cancer.

Authors:  Chen Yang; Siqi Wu; Zezhong Mou; Quan Zhou; Zheyu Zhang; Yiling Chen; Yuxi Ou; Xinan Chen; Xiyu Dai; Chenyang Xu; Na Liu; Haowen Jiang
Journal:  Front Cell Dev Biol       Date:  2021-07-07

Review 4.  Cytokine and Chemokine Signals of T-Cell Exclusion in Tumors.

Authors:  Yu Zhang; Xin-Yuan Guan; Peng Jiang
Journal:  Front Immunol       Date:  2020-12-14       Impact factor: 7.561

Review 5.  Serum Interleukins as Potential Prognostic Biomarkers in HBV-Related Acute-on-Chronic Liver Failure.

Authors:  Lili Zhang; Jianhua Hu; Chunyan Gou; Hua Jin; Chun Zhang; Yang Liu; Yitong Wang; Xiaojun Wang
Journal:  Mediators Inflamm       Date:  2022-09-08       Impact factor: 4.529

6.  HLA-DRB1: A new potential prognostic factor and therapeutic target of cutaneous melanoma and an indicator of tumor microenvironment remodeling.

Authors:  Huiling Deng; Yuxuan Chen; Jiecong Wang; Ran An
Journal:  PLoS One       Date:  2022-09-21       Impact factor: 3.752

Review 7.  Mechanism and strategies of immunotherapy resistance in colorectal cancer.

Authors:  Jiqi Shan; Dong Han; Chunyi Shen; Qingyang Lei; Yi Zhang
Journal:  Front Immunol       Date:  2022-09-27       Impact factor: 8.786

Review 8.  IL-35 Regulates the Function of Immune Cells in Tumor Microenvironment.

Authors:  Kewei Liu; Ai Huang; Jun Nie; Jun Tan; Shijie Xing; Yue Qu; Ke Jiang
Journal:  Front Immunol       Date:  2021-05-21       Impact factor: 7.561

Review 9.  Role of Regulatory T Cells in Regulating Fetal-Maternal Immune Tolerance in Healthy Pregnancies and Reproductive Diseases.

Authors:  Ning Huang; Hongbin Chi; Jie Qiao
Journal:  Front Immunol       Date:  2020-06-26       Impact factor: 7.561
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.